In a groundbreaking study conducted by scientists at IIT Bombay, new findings suggest that collagen, a common structural protein in the body, may play a significant role in exacerbating type 2 diabetes. The research reveals a complex interaction between fibrillar collagen I, which is present in various tissues such as skin and bones, and amylin, a hormone produced alongside insulin in the pancreas. With over 500 million people affected globally by type 2 diabetes, understanding the molecular mechanisms that worsen the disease is of critical importance.
The study, published in the Journal of the American Chemical Society, uncovers a novel biological trigger influencing disease progression. Researchers found that in individuals with diabetes, high levels of amylin can misfold and aggregate, leading to toxic clumps that damage insulin-producing beta cells. What was unclear until this research was how these aggregates are formed. The IIT Bombay team utilized advanced techniques, including atomic force microscopy and nuclear magnetic resonance spectroscopy, to investigate this phenomenon.
Their results indicate that amylin binds to collagen fibrils, accelerating its aggregation process. This interaction appears to create a stable coating of amylin on the collagen, making it more challenging for the body to eliminate these toxic structures. This insight is significant because it highlights the role of the extracellular environment—not just the internal cellular processes—in the progression of diabetes.
Further experiments with pancreatic tissue from diabetic mice and human single-cell data confirmed a correlation: as diabetes advanced, levels of both collagen and amylin increased, leading to disordered pancreatic islets, which are crucial for insulin production. The researchers observed that beta cells cultured on collagen-based gels containing amylin exhibited increased cell death, oxidative stress, and diminished insulin output, underscoring the detrimental effects of this interaction.
These findings may provide explanations for why existing diabetes treatments that target internal cellular mechanisms often fail to halt the advancing disease. The research emphasizes the need for new therapeutic strategies that consider the contribution of the extracellular matrix to diabetes progression.
Looking forward, the research team plans to explore high-resolution imaging techniques, such as cryo-electron microscopy, to further visualize the interaction between amylin and collagen. Additionally, they aim to develop new drugs capable of disrupting this harmful relationship and are investigating the potential for 3D scaffolds to regenerate damaged pancreatic tissue.
Ultimately, this study serves as a crucial reminder that structural components of the body, like collagen, may have unintended consequences in the context of disease, potentially pushing conditions such as diabetes into more severe states. The implications of this research could foster new treatment avenues and improve outcomes for individuals battling type 2 diabetes.
-Raja Aditya
